An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs PEG loxenatide (Primary) ; Digoxin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Jiangsu Hansoh Pharmaceutical
- 21 Jan 2017 Status changed from recruiting to completed.
- 25 Jan 2016 Planned end date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 25 Jan 2016 Planned primary completion date changed from 1 Sep 2015 to 1 May 2016, as reported by ClinicalTrials.gov.